The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.
…
continue reading
In this CME episode, Dr. Andy Cutler interviews Dr. Leslie Citrome about the impact of tardive dyskinesia on patient-reported outcomes and quality of life. They discuss how to correctly assess and diagnose tardive dyskinesia, as well as effective management strategies that incorporate the individual needs of patients. Target Audience: This activity…
…
continue reading
1
E236 - Pediatric Psychopharmacology Series: Deprescribing in Child and Adolescent Psychiatry with Dr. John Walkup
50:31
In the first episode of a special pediatric psychopharmacology series hosted by Dr. Jeffrey Strawn, Dr. John Walkup joins the podcast to discuss deprescribing in pediatric patients. The conversation delves into the situations that warrant deprescribing from antidepressants, selecting the right time to do so, and dealing with relapse, as well as muc…
…
continue reading
This Domestic Violence Awareness Month, we're revisiting an important topic: the often overlooked risk of traumatic brain injury (TBI) among victims of intimate partner violence. Our goal is to shed light on this highly vulnerable group that frequently goes unnoticed in discussions about TBI. By reexamining a previous episode released in March 2020…
…
continue reading
Join Dr. Andy Cutler as he talks with Dr. Joan Striebel about the syndrome of catatonia, including its dynamic presentation, treating the underlying disorder, and why clinicians must raise their index of suspicion when evaluating symptoms that could indicate catatonia is present. Dr. Joan Striebel is a psychiatrist at the California Department of S…
…
continue reading
In this CME episode, Dr. Andrew Cutler interviews Dr. Charles Vega about the challenges of identifying bipolar disorder in primary care and how to over come them. They also discuss strategies for initiating and managing pharmacological treatment long term in collaboration with patients and psychiatric specialists. Target Audience: This activity has…
…
continue reading
1
E232 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: Clozapine with Dr. Jonathan Meyer
52:29
What are the primary barriers to clozapine utilization in the United States, and how do these barriers impact patient care? What are some common misconceptions or negative attitudes among prescribers regarding clozapine, and how can these be addressed? What are some effective strategies for improving the management of clozapine’s side effects to en…
…
continue reading
1
E231 - The 2023 NEI Congress Young Investigator Poster Competition #1 Poster with Dr. Richard Price
49:56
Join Dr. Andy Cutler as he talks with the co-author of the winning poster from the 2023 NEI Congress Young Investigator Poster Competition, Dr. Richard Price. They discuss the objectives, design, and key findings of the poster titled, “Improved Mood and Weight Gain Mitigation Following Switch from Aripiprazole to Cariprazine.” They also discuss the…
…
continue reading
1
E230 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: MAOIs with Dr. Thomas Schwartz
51:31
What are the main reasons MAOIs are underutilized in psychiatric practice despite their proven efficacy for certain conditions? What are the key dietary restrictions patients must follow when taking MAOIs? What are the critical drug-drug interactions clinicians must be aware of when prescribing MAOIs? What clinical pearls or tips would you give to …
…
continue reading
1
E229 - Treatment Approaches for Smoking Cessation in the LGBTQIA+ Community with Dr. Rhonda Schwindt
1:02:38
1:02:38
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto
1:02:38
What are the current smoking rates among LGBTQIA+ individuals compared to the general population? What unique barriers do LGBTQIA+ individuals face when trying to quit smoking? What are the recommended pharmacotherapies and behavioral interventions for smoking cessation? What training is needed for providers to deliver culturally affirmative smokin…
…
continue reading
1
E228 - (CME) Tardive Dyskinesia Today: Updates in the Current Landscape of Tardive Dyskinesia
1:07:06
1:07:06
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto
1:07:06
In this CME episode, Dr. Andrew Cutler interviews Dr. Laxman Bahroo about the current landscape of tardive dyskinesia, including screening, diagnosis, and treatment. Practical strategies based on the latest data are reviewed at length, particularly for long-term management of tardive dyskinesia. Target Audience: This activity has been developed for…
…
continue reading
1
E227 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: Lithium with Dr. Jonathan Meyer
1:03:34
1:03:34
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto
1:03:34
What are the properties of lithium that make it a unique treatment option? What are the main reasons why lithium is underutilized in clinical practice, and what are the consequences of underutilization? What are the common myths or misconceptions about lithium’s safety and tolerability? How can we better educate patients about the benefits of lithi…
…
continue reading
In this CME episode, Dr. Andrew Cutler interviews Desiree Matthews, PMHNP-BC on the importance of engaging patients across all facets of tardive dyskinesia management beginning with screening to symptoms monitoring to treatment. The role of patient experience and preferences in shared decision-making regarding treatment for tardive dyskinesia is di…
…
continue reading
1
E225 - The PsychopharmaStahlogy Show: Untreatable Dimensions of Psychopathology: Agitation with Dr. Leslie Citrome
52:38
How do symptoms of agitation manifest differently in disorders such as bipolar disorder, schizophrenia, and dementia, and what challenges does this pose for assessment? What are the most effective pharmacological treatments for acute agitation in psychiatric patients, and how do you determine the best course of action? How do cultural factors influ…
…
continue reading
What are the hypothesized neurobiological mechanisms that support the use of cannabidiol (CBD) as a treatment for opioid use disorder (OUD)? How does CBD influence cue-induced craving in OUD? What are the challenges and opportunities in further exploring the use of CBD as a potential treatment for OUD? Dr. Joji Suzuki is the Director of the Divisio…
…
continue reading
1
E223 - 2024 NEI Synapse Extended Q&A: Diagnosing and Treating Comorbid ADHD and Bipolar Disorder with Dr. David Goodman
27:34
In this episode, Dr. David Goodman addresses your unanswered questions from his presentation, Setting the Mood: Strategies for Diagnosing and Treating ADHD in the Context of Bipolar Disorder, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
…
continue reading
1
E222 - 2024 NEI Synapse Extended Q&A: Recognizing and Treating Mixed Features Across the Lifespan with Dr. Manpreet Singh
21:15
In this episode, Dr. Manpreet Singh addresses your unanswered questions from her joint presentation, Don’t Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
…
continue reading
1
E221 - 2024 NEI Synapse Extended Q&A: Diagnosis and Treatment of Alzheimer’s Disease with Dr. Dani Cabral
13:49
In this episode, Dr. Dani Cabral addresses your unanswered questions from her presentation, Memories in the Future: An Update on the Diagnosis and Treatment of Alzheimer’s Disease, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
…
continue reading
1
E220 - 2024 NEI Synapse Extended Q&A: A Collaborative Approach to SMI Treatment with Dr. Sarah Vinson
25:57
In this episode, Dr. Sarah Vinson addresses your unanswered questions from her panel presentation, Serious Mental Illness: A Collaborative Approach, delivered at 2024 NEI Synapse in Las Vegas, Nevada.
…
continue reading
1
E219 - The PsychopharmaStahlogy Show: Untreatable Dimensions of Psychopathology: Cognitive Dysfunction with Dr. Richard Keefe
1:04:48
1:04:48
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto
1:04:48
How does dysfunction in cognition affect overall treatment outcomes for psychiatric disorders? What are the challenges in treating cognitive deficits in psychiatric conditions? What treatments are in development for cognitive dysfunction? Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controve…
…
continue reading
What are some common challenges faced by caregivers of individuals with dementia? What is comprehensive dementia care and how does it improve quality of life of individuals with dementia and their caregivers? What is the GUIDE Model and why is it needed? Carolyn Clevenger, DNP, RN, GNP-BC, AGPCNP-BC, FAANP, FGSA is a Professor at the Nell Hodgson W…
…
continue reading
What is the role of mindfulness techniques in the treatment of anxiety disorders and how is it evolving? How does mindfulness-based stress reduction compare to pharmacological treatment for anxiety disorders? What are the hypotheses that have been made about why mindfulness-based treatments work for anxiety? Elizabeth Hoge, MD is a Professor and Di…
…
continue reading
What are the cultural factors that should be considered when providing mental health care to migrant and refugee populations? What challenges and opportunities exist in providing mental health care to these communities? How can mental health professionals collaborate with other disciplines to create a holistic approach to address the mental health …
…
continue reading
1
E215 - The PsychopharmaStahlogy Show: Untreatable Dimensions of Psychopathology: Anhedonia with Dr. Vladimir Maletic
47:43
How does anhedonia impact the overall treatment plan for patients with major depressive disorder and other psychiatric conditions? What are some of the most challenging aspects of treating anhedonia in patients? Are there any new treatments in development that may be helpful for treating anhedonia? Brought to you by the NEI Podcast, the Psychopharm…
…
continue reading
1
E214 - Re-Release: Blazing Trails to Break Down Structural Racism and Improve Black Mental Health with Dr. Sarah Vinson
21:37
During Black History Month, we revisit an enlightening conversation with Dr. Sarah Vinson about the impact of structural racism on Black mental health and how mental healthcare providers can make a difference in the lives of patients by leveraging their privilege and skillsets. Dr. Sarah Y. Vinson is a physician who is triple-board certified in adu…
…
continue reading
1
E213 - The PsychopharmaStahlogy Show: Is The Trip Necessary? with Dr. Charles Raison
1:01:33
1:01:33
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto
1:01:33
Can the therapeutic benefits of psilocybin be achieved without a psychedelic trip? What is the role of psychological support in the therapeutic effect of psilocybin? What is microdosing and what are its potential benefits and risks? What is the path to FDA approval and commercialization of psilocybin and other psychedelics? Brought to you by the NE…
…
continue reading
The climate crisis has a wide-reaching impact that negatively affects both acute and long-lasting mental health outcomes. Are there specific populations that are more vulnerable to mental health issues related to the climate crisis? What is the role of mental health professional to combat the negative influence of climate change on mental health? R…
…
continue reading
1
E211 - (CME) More Than Memories: An Update on the Diagnosis and Treatment of Alzheimer’s Disease
1:00:04
1:00:04
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto
1:00:04
In this CME episode, Dr. Andrew Cutler interviews Dr. Dani Cabral about current and novel diagnostic tools and treatments for Alzheimer’s disease. Optional CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CE credit, click nei.global/POD23-MDD Learning Objectives: After completing thi…
…
continue reading
1
E210 - The PsychopharmaStahlogy Show: Potential Therapeutic Indications for Psychedelics with Dr. Scott Aaronson
58:41
What do the clinical trials of psilocybin and other psychedelics show in terms of efficacy and safety? How much of the benefit with psychedelic treatment is attributable to psychological support? Is the psychedelic trip important for the therapeutic benefits of psychedelic treatments? Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show…
…
continue reading
1
E209 - (CME) Harnessing Pharmacogenomic Testing as a Tool in Major Depressive Disorder Treatment
1:02:22
1:02:22
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto
1:02:22
In this CME episode, Dr. Andrew Cutler interviews Dr. Jeffrey Strawn about the role of pharmacogenomic testing in guiding treatment of major depressive disorder (MDD). They discuss how pharmacogenomic testing works, the impact of failed treatments and side effects on patients with MDD, and the clinical applications and future directions of pharmaco…
…
continue reading
1
E208 - A Look Back at This Year in Psychopharmacology with Dr. Roger McIntyre
1:08:42
1:08:42
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto
1:08:42
What were some new treatments approved by the FDA? What did we learn about the long-term safety of methylphenidate in childhood ADHD? Are there benefits to long-term maintenance treatment with antidepressants in bipolar disorder? What did we learn about the safety and efficacy of subcutaneous racemic ketamine for treatment-resistant depression and …
…
continue reading
1
E207 - (CME) Don’t Forget About Me: Addressing Residual Symptoms in Major Depressive Disorder
1:01:09
1:01:09
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto
1:01:09
In this CME episode, Dr. Andrew Cutler interviews Dr. Vladimir Maletic about the impact of residual symptoms on patients with major depressive disorder, as well as treatment modifications to address residual symptoms in these individuals. Optional CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional post…
…
continue reading
1
E206 - 2023 NEI Congress Extended Q&A: Anhedonia and Emotional Blunting with Dr. Vladimir Maletic
11:52
In this episode, Dr. Vladimir Maletic addresses your unanswered questions from his presentations, “From Despair to Delight: Advances in the Diagnosis and Treatment of Anhedonia” and “Ho Hum to Aha! Treating Anhedonia and Emotional Blunting.”
…
continue reading
In this episode, Dr. Leslie Citrome addresses your unanswered questions from his presentation, There’s No Place Like Home: Addressing Agitation in Dementia.
…
continue reading
1
E204 - The PsychopharmaStahlogy Show: How Do Psychedelics Work Anyway? with Dr. Roger McIntyre
59:36
What is the role of the 5HT2A receptor in the therapeutic actions of psychedelics? What additional mechanisms may be involved in the therapeutic benefits of classic psychedelics? Is the psychedelic trip necessary for the therapeutic benefit of psychedelics? Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exc…
…
continue reading
In this episode, Dr. Laxman Bahroo addresses your unanswered questions from his presentation, Neurology for Psychiatrists.
…
continue reading
1
E202 - 2023 NEI Congress Extended Q&A: Therapeutic Potential of Psychedelics with Dr. Roger McIntyre
22:17
In this episode, Dr. Roger McIntyre addresses your unanswered questions from his presentation, Unveiling the Therapeutic Potential: Evidence Supporting the Use of Psychedelics for PTSD, SUD, and Other Indications, at the Pre-Conference Psychedelics Workshop.
…
continue reading
1
E201 - 2023 NEI Congress Extended Q&A: Juvenile Bipolar Disorder and ADHD with Dr. Timothy Wilens
16:03
In this episode, Dr. Timothy Wilens addresses your unanswered questions from his presentation, Double Trouble: Diagnosis and Pharmacotherapy of ADHD and Juvenile Bipolar Disorder, at the Child & Adolescent Psychiatry Academy.
…
continue reading
1
E200 - 2023 NEI Congress Extended Q&A: Autism Spectrum Disorder and Comorbidities with Dr. Robyn Thom
15:19
In this episode, Dr. Robyn Thom addresses your unanswered questions from her presentation, The Full Picture: Managing Autism Spectrum Disorder and Its Frequent Psychiatric Comorbidities, at the Child & Adolescent Psychiatry Academy.
…
continue reading
1
E199 - 2023 NEI Congress Extended Q&A: Comorbid Anxiety in Childhood with Dr. Jeffrey Strawn
12:52
In this episode, Dr. Jeffrey Strawn addresses your unanswered questions from his presentation, Along for the Ride: Treatment Considerations for Childhood Psychiatric Disorders With Co-Occurring Anxiety, at the Child & Adolescent Psychiatry Academy.
…
continue reading
Stigma surrounding mental illness and its treatment can be pervasive and negatively impact the quality of life of patients suffering with mental health problems. What role do psychiatric healthcare providers play in addressing and combating mental illness stigma? How do cultural factors influence the perception of mental illness and stigma? What ar…
…
continue reading
The 19th annual NEI Congress is upon us. Whether you’ve already secured your spot to join us in person at The Broadmoor in Colorado Springs or plan to attend virtually via simulcast OR are still unsure if this event is for you, you’re in luck. This is our Congress preview episode. Congress chairman, Dr. Andrew Cutler interviews a few of the brillia…
…
continue reading
1
E196 - The PsychopharmaStahlogy Show: Classic Psychedelics for the Modern Psychopharmacologist: Good or Evil?
48:51
What are classic psychedelic drugs and how has their role in psychiatry changed over time? What are the potential benefits of using psychedelic therapy for treating psychiatric disorders? Are there any significant risks and what are the potential side effects associated with psychedelic therapy? Brought to you by the NEI Podcast, the PsychopharmaSt…
…
continue reading
1
E195 - Adherence and Therapeutic Alliance in the SMI Population with Dr. Peter Weiden
1:03:12
1:03:12
Riproduci in seguito
Riproduci in seguito
Liste
Like
Like aggiunto
1:03:12
How large of an issue is treatment non-adherence in the serious mental illness (SMI) population? How does therapeutic alliance influence treatment adherence? What are some effective strategies for improving medication adherence? Dr. Andrew Cutler interviews Dr. Peter Weiden to find answers to these questions and more! Peter J. Weiden, MD is an inte…
…
continue reading
In this re-release episode, Dr. Andrew Cutler interviews Dr. Katherine Warburton about the history of criminalization of serious mental illness, the efforts to decriminalize mental illness, and the development and success of diversion programs. Dr. Katherine Warburton is Medical Director/Deputy Director of Clinical Operations for the California Dep…
…
continue reading
1
E193 - Re-Release: Refreshing Perspectives on Recovery: September is National Recovery Month with Dr. Nzinga Harrison (E82)
45:41
During National Recovery Month, we are re-releasing this classic episode in which Dr. Sabrina Segal interviews addiction expert Dr. Nzinga Harrison about the need to address stigma and misconceptions surrounding the topic of addiction. When it comes to addiction, there are many questions. What does it mean to say that someone is in recovery? What a…
…
continue reading
In this re-release episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl about the dark side of neuroplasticity, or pathologic neuroplasticity, and what we may be able to do to combat it.
…
continue reading
1
E191 - Re-Release: Sounds of Science: The Clinical Application of Auditory Neuroscience with Dr. Nina Kraus (E141)
55:12
What led you to pursue a career in auditory neuroscience and what is the mission behind your laboratory, Brainvolts? What is the effect of bilingualism on Alzheimer’s disease? How can sound be used for the assessment of traumatic brain injury and other neurological conditions? In this episode, Dr. Nina Kraus addresses these questions and much more …
…
continue reading
In this CME episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl and Dr. Sarah Vinson about the ethicality and morality of involuntary treatment for serious mental illness (SMI), the relationship between SMI and the criminal justice system, and community-based changes that are being pursued to improve treatment and reduce the criminalization of …
…
continue reading
In this re-release episode, Dr. Andrew Cutler interviews Drs. Marko Perko and Stephen Stahl about their book, Tesla: His Tremendous and Troubled Life, which explores the intersection between Tesla’s genius, his creativity, and his bipolar disorder. Sadly, Dr. Marko Perko passed away last fall after a battle with cancer. He was a prolific writer and…
…
continue reading
1
E188 - Re-Release: Improved Mental Health Treatment Through Collaborative Care with Dr. Anna Ratzliff (E120)
37:10
NEI Podcast is taking a temporary hiatus over the summer. From July through September, we will revisit some of our most compelling episodes, on topics that remain as relevant today as when they first aired. New episodes will resume in the fall; make sure you are subscribed so that you don’t miss out! ***************************** What is unique abo…
…
continue reading